Log In
BCIQ
Print this Print this
 

CTAP201

  Manage Alerts
Collapse Summary General Information
Company Opko Health Inc.
DescriptionVitamin D hormone therapy
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationThyroid disease
Indication DetailsTreat secondary hyperparathyroidism (SHPT) in chronic kidney disease (CKD) patients
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today